Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratory

[1]  A. Fournier,et al.  Neuroprotective Function of 14-3-3 Proteins in Neurodegeneration , 2013, BioMed research international.

[2]  A. Bizzi,et al.  A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease , 2012, Neurology.

[3]  K. Satoh,et al.  High sensitivity of an ELISA kit for detection of the gamma-isoform of 14-3-3 proteins: usefulness in laboratory diagnosis of human prion disease , 2011, BMC neurology.

[4]  A. Cagnin,et al.  Cerebrospinal Fluid Markers in Sporadic Creutzfeldt-Jakob Disease , 2011, International Journal of Molecular Sciences.

[5]  Xiongwei Zhu,et al.  Cell cycle deregulation in the neurons of Alzheimer's disease. , 2011, Results and problems in cell differentiation.

[6]  W. Zhou,et al.  Elevated Levels of Tau Protein in Cerebrospinal Fluid of Patients With Probable Creutzfeldt-Jakob Disease , 2010, The American journal of the medical sciences.

[7]  H. Kretzschmar,et al.  14-3-3 CSF levels in sporadic Creutzfeldt–Jakob disease differ across molecular subtypes , 2009, Neurobiology of Aging.

[8]  P. Johannsen,et al.  The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease , 2009, Neurobiology of Aging.

[9]  C. Begue,et al.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease , 2009, Brain : a journal of neurology.

[10]  M. Takeda,et al.  Phosphorylation of tau at Ser214 mediates its interaction with 14‐3‐3 protein: implications for the mechanism of tau aggregation , 2009, Journal of neurochemistry.

[11]  K. Eguchi,et al.  Total Tau Protein in Cerebrospinal Fluid and Diffusion-Weighted MRI as an Early Diagnostic Marker for Creutzfeldt-Jakob Disease , 2007, Dementia and Geriatric Cognitive Disorders.

[12]  H. Monaco,et al.  Detection of CSF 14-3-3 protein in Guillain–Barré syndrome , 2006, Neurology.

[13]  K. Eguchi,et al.  14-3-3 Protein, Total Tau and Phosphorylated Tau in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease and Neurodegenerative Disease in Japan , 2006, Cellular and Molecular Neurobiology.

[14]  K. Blennow,et al.  Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt–Jakob disease , 2006, Neurobiology of Aging.

[15]  K. Blennow,et al.  Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease. , 2005, International journal of molecular medicine.

[16]  H. Monaco,et al.  Phosphorylated 14-3-3ζ protein in the CSF of neuroleptic-treated patients , 2005, Neurology.

[17]  J. Wiltfang,et al.  Follow-Up Investigations of Tau Protein and S-100B Levels in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease , 2005, Dementia and Geriatric Cognitive Disorders.

[18]  R. Castellani,et al.  Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease , 2004, Neurology.

[19]  C. MacKintosh,et al.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.

[20]  Jesus Avila,et al.  Role of tau protein in both physiological and pathological conditions. , 2004, Physiological reviews.

[21]  J. Martín,et al.  A prospective study of CSF markers in 250 patients with possible Creutzfeldt–Jakob disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[22]  N. Barbaro,et al.  Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. , 2003, Archives of neurology.

[23]  H. Paudel,et al.  14-3-3 Connects Glycogen Synthase Kinase-3β to Tau within a Brain Microtubule-associated Tau Phosphorylation Complex* , 2003, The Journal of Biological Chemistry.

[24]  H. Vanderstichele,et al.  Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt–Jakob disease from other dementias , 2003, Molecular Psychiatry.

[25]  R. Sánchez-Valle,et al.  14-3-3 protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt–Jakob disease , 2002, Neuroscience Letters.

[26]  J. Wiltfang,et al.  Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease , 2002, Neurology.

[27]  A. Lowman,et al.  Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt–Jakob disease , 2001, Neurology.

[28]  C. Gibbs,et al.  An enzyme‐linked immunosorbent assay to quantify 14‐3‐3 proteins in the cerebrospinal fluid of suspected Creutzfeldt‐Jakob disease patients , 2000, Annals of neurology.

[29]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[30]  Y. Kim,et al.  Molecular analysis of prion protein gene (PRNP) in Korean patients with Creutzfeldt-Jakob disease. , 1998, Journal of Korean medical science.

[31]  C. Der,et al.  14-3-3 ζ Negatively Regulates Raf-1 Activity by Interactions with the Raf-1 Cysteine-rich Domain* , 1997, The Journal of Biological Chemistry.

[32]  J Q Trojanowski,et al.  Molecular basis of phenotypic variability in sporadc creudeldt‐jakob disease , 1996, Annals of neurology.